Brief: Cipher Pharmaceuticals Q3 EPS $0.03 From Continuing Operations

Cipher Pharmaceuticals

07/11/2018 12:17

Nov 7 (Reuters) - Cipher Pharmaceuticals Inc  CPH.TO :
    * CIPHER PHARMACEUTICALS REPORTS Q3 2018 RESULTS
    * Q3 EARNINGS PER SHARE $0.03 FROM CONTINUING OPERATIONS
    * Q3 REVENUE $4.8 MILLION VERSUS $10 MILLION
    * Q3 EARNINGS PER SHARE VIEW $0.10, REVENUE VIEW $6.9
MILLION --
THOMSON REUTERS I/B/E/S
    * CIPHER PHARMACEUTICALS - IN Q4 2018, EXPECTS PRESCRIPTIONS
FOR
ABSORICA TO INCREASE VERSUS Q3 2018 DUE TO SEASONALITY OF
PRODUCT

Source text for Eikon:  ID:nCNW9JVBLa 
Further company coverage:  CPH.TO 

 ((Reuters.Briefs@thomsonreuters.com;))